Published in Acta Biomater on October 13, 2014
Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells. Hepatology (2016) 0.83
Hyaluronan as a therapeutic target in human diseases. Adv Drug Deliv Rev (2015) 0.81
Paving the TRAIL to anti-fibrotic therapy. Hepatology (2016) 0.75
Development of a high quantum yield dye for tumour imaging. Chem Sci (2017) 0.75
Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma. Oncotarget (2017) 0.75
Bioimaging and pulmonary applications of self-assembled Flt1 peptide-hyaluronic acid conjugate nanoparticles. Biomaterials (2013) 0.81
Transdermal delivery of hyaluronic acid -- human growth hormone conjugate. Biomaterials (2012) 0.75
Development and validation of a reversed-phase fluorescence HPLC method for determination of bucillamine in human plasma using pre-column derivatization with monobromobimane. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.75